Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-072044
Filing Date
2025-05-15
Accepted
2025-05-15 08:52:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 15769
  Complete submission text file 0000950170-25-072044.txt   17439
Mailing Address 50 BEALE STREET, STE 2300 SAN FRANCISCO CA 94105
Business Address 50 BEALE STREET, STE 2300 SAN FRANCISCO CA 94105 4159677763
ICONIQ Strategic Partners V, L.P. (Filed by) CIK: 0001816067 (see all company filings)

EIN.: 981538365 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Subject) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93478 | Film No.: 25949034
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)